FdaApplication

ANDA 214543

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSOMERSET THERAPEUTICS LLC
application_typeANDA
approval_date2021-05-05

Products (3)

ProductActive ingredientStrengthDosage form
DROXIDOPADROXIDOPA300MGCAPSULE;ORAL
DROXIDOPADROXIDOPA200MGCAPSULE;ORAL
DROXIDOPADROXIDOPA100MGCAPSULE;ORAL

3 products